Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Personalis | PSNL | Mar 17, 2025 | 3.80 | +4.68 |
Perspective Therapeutics | CATX | Mar 17, 2025 | 2.60 | +0.39 |
Petco Health And Wellness | WOOF | Mar 17, 2025 | 2.50 | +4.60 |
PetMed Express | PETS | Mar 17, 2025 | 4.00 | -0.50 |
Petroleo Brasileiro S.A.- Petrobras ADR | PBR | Mar 17, 2025 | 13.90 | +3.50 |
Petroleo Brasileiro S.A.- Petrobras ADR Pref | PBR-A | Mar 17, 2025 | 12.79 | +2.73 |
Petros Pharmaceuticals | PTPI | Mar 17, 2025 | 0.08 | -7.70 |
Pfizer | PFE | Mar 17, 2025 | 26.05 | +1.28 |
PG&E Pref A | PCG-X | Mar 17, 2025 | 43.74 | 0.00 |
Pgim Global High Yield Fund | GHY | Mar 17, 2025 | 12.93 | -0.15 |
Pgim High Yield Bond Fund | ISD | Mar 17, 2025 | 13.97 | +0.72 |
PGIM Short Duration High Yield Opportunities Fund | SDHY | Mar 17, 2025 | 16.48 | +1.35 |
Pharmaceutical ETF Market Vectors | PPH | Mar 17, 2025 | 93.29 | +1.57 |
PharmaCyte Biotech | PMCB | Mar 17, 2025 | 1.58 | 0.00 |
Pharming Group ADR | PHAR | Mar 17, 2025 | 8.80 | -1.72 |
Pharvaris | PHVS | Mar 17, 2025 | 16.50 | -1.02 |
Phathom Pharmaceuticals | PHAT | Mar 17, 2025 | 4.84 | +9.75 |
PhenixFIN | PFX | Mar 17, 2025 | 54.01 | -0.31 |
Pheton | PTHL | Mar 17, 2025 | 3.67 | -12.20 |
Phibro Animal Health A | PAHC | Mar 17, 2025 | 21.85 | +2.82 |
Philip Morris | PM | Mar 17, 2025 | 155.71 | +2.52 |
Philippines Invstb Mkt Idx MSCI Ishares | EPHE | Mar 17, 2025 | 26.00 | +0.83 |
Phillips 66 | PSX | Mar 17, 2025 | 129.19 | +1.94 |
Phillips Edison & Company | PECO | Mar 17, 2025 | 35.13 | +0.92 |
PHINIA | PHIN | Mar 17, 2025 | 42.58 | -0.70 |
Phio Pharmaceuticals | PHIO | Mar 17, 2025 | 1.36 | +5.43 |
PHLX Semiconductor | SOX | Mar 17, 2025 | 4 663.97 | +1.42 |
PHLX Sox Semiconductor Sector Ishares | SOXX | Mar 17, 2025 | 204.44 | +1.65 |
Phoenix Motor | PEV | Mar 17, 2025 | 0.67 | +0.36 |
Phoenix New Media A ADR | FENG | Mar 17, 2025 | 2.28 | +8.57 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.